These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 37417769)

  • 1. Engineering and Characterization of an Artificial Drug-Carrying Vesicles Nanoplatform for Enhanced Specifically Targeted Therapy of Glioblastoma.
    Liu J; Sun Y; Zeng X; Liu Y; Liu C; Zhou Y; Liu Y; Sun G; Guo M
    Adv Mater; 2023 Oct; 35(41):e2303660. PubMed ID: 37417769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effective and Targeted Human Orthotopic Glioblastoma Xenograft Therapy via a Multifunctional Biomimetic Nanomedicine.
    Zou Y; Liu Y; Yang Z; Zhang D; Lu Y; Zheng M; Xue X; Geng J; Chung R; Shi B
    Adv Mater; 2018 Dec; 30(51):e1803717. PubMed ID: 30328157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multifunctional exosome-mimetics for targeted anti-glioblastoma therapy by manipulating protein corona.
    Wu JY; Li YJ; Wang J; Hu XB; Huang S; Luo S; Xiang DX
    J Nanobiotechnology; 2021 Dec; 19(1):405. PubMed ID: 34872569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiopep-2-Modified Carboxymethyl Chitosan-Based pH/Reduction Dual-Stimuli-Responsive Nanogels for Enhanced Targeting Glioblastoma.
    Song P; Song N; Li L; Wu M; Lu Z; Zhao X
    Biomacromolecules; 2021 Jul; 22(7):2921-2934. PubMed ID: 34180218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiopep-2 Grafted PAMAM Dendrimers for the Targeted Delivery of Temozolomide:
    Sahoo RK; Kumar H; Jain V; Sinha S; Ajazuddin ; Gupta U
    ACS Biomater Sci Eng; 2023 Jul; 9(7):4288-4301. PubMed ID: 37307155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted Delivery of Functionalized Upconversion Nanoparticles for Externally Triggered Photothermal/Photodynamic Therapies of Brain Glioblastoma.
    Tsai YC; Vijayaraghavan P; Chiang WH; Chen HH; Liu TI; Shen MY; Omoto A; Kamimura M; Soga K; Chiu HC
    Theranostics; 2018; 8(5):1435-1448. PubMed ID: 29507632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delivery of siRNA based on engineered exosomes for glioblastoma therapy by targeting STAT3.
    Liang SF; Zuo FF; Yin BC; Ye BC
    Biomater Sci; 2022 Mar; 10(6):1582-1590. PubMed ID: 35179533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single siRNA Nanocapsules for Effective siRNA Brain Delivery and Glioblastoma Treatment.
    Zou Y; Sun X; Wang Y; Yan C; Liu Y; Li J; Zhang D; Zheng M; Chung RS; Shi B
    Adv Mater; 2020 Jun; 32(24):e2000416. PubMed ID: 32374446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Doxorubicin-loaded iron oxide nanoparticles for glioblastoma therapy: a combinational approach for enhanced delivery of nanoparticles.
    Norouzi M; Yathindranath V; Thliveris JA; Kopec BM; Siahaan TJ; Miller DW
    Sci Rep; 2020 Jul; 10(1):11292. PubMed ID: 32647151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Membrane-Decorated Exosomes for Combination Drug Delivery and Improved Glioma Therapy.
    Liang S; Xu H; Ye BC
    Langmuir; 2022 Jan; 38(1):299-308. PubMed ID: 34936368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel dual targeting cubosomes modified with angiopep-2 for co-delivery GNA and PLHSpT to brain glioma.
    Lin T; Wei Q; Zhang H; Yang Y; Jiang B; Wang Z; Li S; Wang Q; Hu M; Chen W; Wang L; Ding B
    J Biomater Appl; 2024 Jan; 38(6):743-757. PubMed ID: 38000075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biomimetic Dp44mT-nanoparticles selectively induce apoptosis in Cu-loaded glioblastoma resulting in potent growth inhibition.
    Ismail M; Yang W; Li Y; Wang Y; He W; Wang J; Muhammad P; Chaston TB; Rehman FU; Zheng M; Lovejoy DB; Shi B
    Biomaterials; 2022 Oct; 289():121760. PubMed ID: 36044788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimizing the Design of Blood-Brain Barrier-Penetrating Polymer-Lipid-Hybrid Nanoparticles for Delivering Anticancer Drugs to Glioblastoma.
    Ahmed T; Liu FF; He C; Abbasi AZ; Cai P; Rauth AM; Henderson JT; Wu XY
    Pharm Res; 2021 Nov; 38(11):1897-1914. PubMed ID: 34655006
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dual-targeting immunoliposomes using angiopep-2 and CD133 antibody for glioblastoma stem cells.
    Kim JS; Shin DH; Kim JS
    J Control Release; 2018 Jan; 269():245-257. PubMed ID: 29162480
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apolipoprotein E Peptide-Directed Chimeric Polymersomes Mediate an Ultrahigh-Efficiency Targeted Protein Therapy for Glioblastoma.
    Jiang Y; Zhang J; Meng F; Zhong Z
    ACS Nano; 2018 Nov; 12(11):11070-11079. PubMed ID: 30395440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specific anti-glioma targeted-delivery strategy of engineered small extracellular vesicles dual-functionalised by Angiopep-2 and TAT peptides.
    Zhu Z; Zhai Y; Hao Y; Wang Q; Han F; Zheng W; Hong J; Cui L; Jin W; Ma S; Yang L; Cheng G
    J Extracell Vesicles; 2022 Aug; 11(8):e12255. PubMed ID: 35932288
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Charge Conversional Biomimetic Nanocomplexes as a Multifunctional Platform for Boosting Orthotopic Glioblastoma RNAi Therapy.
    Liu Y; Zou Y; Feng C; Lee A; Yin J; Chung R; Park JB; Rizos H; Tao W; Zheng M; Farokhzad OC; Shi B
    Nano Lett; 2020 Mar; 20(3):1637-1646. PubMed ID: 32013452
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brain delivery of Plk1 inhibitor via chimaeric polypeptide polymersomes for safe and superb treatment of orthotopic glioblastoma.
    Fan Q; Liu Y; Cui G; Zhong Z; Deng C
    J Control Release; 2021 Jan; 329():1139-1149. PubMed ID: 33131697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synchronous Disintegration of Ferroptosis Defense Axis via Engineered Exosome-Conjugated Magnetic Nanoparticles for Glioblastoma Therapy.
    Li B; Chen X; Qiu W; Zhao R; Duan J; Zhang S; Pan Z; Zhao S; Guo Q; Qi Y; Wang W; Deng L; Ni S; Sang Y; Xue H; Liu H; Li G
    Adv Sci (Weinh); 2022 Jun; 9(17):e2105451. PubMed ID: 35508804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted nano-delivery of chemotherapy via intranasal route suppresses in vivo glioblastoma growth and prolongs survival in the intracranial mouse model.
    Sandbhor P; Goda J; Mohanty B; Gera P; Yadav S; Chekuri G; Chaudhari P; Dutt S; Banerjee R
    Drug Deliv Transl Res; 2023 Feb; 13(2):608-626. PubMed ID: 36245060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.